Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Ionis Pharmaceuticals | IONS - Kreditur Perdagangan
Keuangan
Harga Saham
USD
Aktiva
USD 2.99B
Kas Dan Setara
USD 350.07M
Biaya Penjualan
USD 2.74M
Aset Lancar
USD 2.49B
Kewajiban Lancar
USD 315.64M
UTANG
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
Karyawan
1.07K
Eps Laba Per Saham
USD -0.69
Modal Dan Cadangan
USD 439.74M
Laba Kotor Pada Penjualan
USD 265M
Beban Bunga Utang
USD 18M
Pendapatan Bunga
USD -0.66
Modal Pinjaman
USD 1.91B
Kapitalisasi Pasar
USD 8.22B
Batas Pemasukan
USD -114.65M
Biaya Operasional
USD 370.24M
Laba Operasional
USD -102.29M
Modal Saham Biasa
USD 165.64M
Pe Harga Untuk Laba
396.15
Laba Sebelum Pajak
USD -114M
Pendapatan Penjualan
USD 268M
Beban Penjualan Dan Administrasi
USD 130.08M
Saham
USD 50.83M
Kreditur Perdagangan
USD 47.7M
Debitur Perdagangan
USD 58.85M
Kreditur Perdagangan
Perubahan
Tanggal
Agios Pharmaceuticals
USD 16.34M
2.6M
2026-06
Alnylam Pharmaceuticals
USD 108.02M
18.61M
2026-06
Arrowhead Research
USD 27.78M
2.97M
2026-06
Astellas Pharma
JPY 192.29B
7.47B
2026-06
BioCryst Pharmaceuticals
USD 11.46M
501K
2026-06
BioMarin Pharmaceutical
USD 913.67M
120.52M
2026-06
Celltrion
KRW 88.58B
9.9B
2026-03
Cspc Pharmaceutical
CNY 2.32B
236.83M
2025-12
Deva Holding AS
TRY 809.81M
105.88M
2023-09
Divis Laboratories Ltd
INR 12.11B
1.71B
2026-03
Exelixis
USD 39.06M
14.91M
2026-06
Halozyme Therapeutics
USD 23.61M
9.51M
2026-06
Ionis Pharmaceuticals
USD 47.7M
21.67M
2026-06
Kangmei Pharma
CNY 2.46B
153.5M
2026-03
Knight Therapeutics
CAD 125.76M
7.63M
2025-12
Laboratorios Farma
EUR 107.59M
341K
2023-12
Malin Corporation
EUR 700K
200K
2024-12
Medical Developments International
AUD 4.31M
2.18M
2025-12
Moderna
USD 167M
6M
2026-06
Nektar Therapeutics
USD 10.03M
744K
2026-03
Neuren Pharmaceuticals
AUD 2.4M
4.26M
2025-12
Neurocrine Biosciences
USD 691.3M
145.8M
2026-03
Novartis
USD 4.26B
64M
2026-06
Omeros
USD 8.84M
4.42M
2025-06
OPKO Health
USD 44.18M
3.07M
2026-03
Organigram Holdings
CAD 73.14M
2.06M
2026-03
Ovoca Bio
EUR 1.3M
1.11M
2025-12
Pfizer
USD 4.58B
75M
2026-06
Pharma Mar
EUR 38.93M
4.9M
2026-06
PTC Therapeutics
USD 40.45M
14.96M
2026-06
Qiagen NV
USD 79.08M
785K
2026-06
Regeneron Pharmaceuticals
USD 1.16B
132.2M
2026-06
Roche Holding
CHF 5.54B
237M
2026-06
Sarepta Therapeutics
USD 50.98M
19.39M
2026-06
Sartorius
EUR 329.1M
16.2M
2026-06
Sino Biopharmaceutical
CNY 2.82B
1.32B
2025-06
Tilray
USD 114.5M
3.69M
2025-09
Ultragenyx Pharmaceutical
USD 39M
3M
2026-06
Vertex Pharmaceuticals
USD 3.61B
135M
2026-06
Zealand Pharma A/S
171M
175.6M
2026-03
Zz Pientze Pharmaceu
CNY 457.05M
59.09M
2026-03
×